ARCH and Population Health partner with Haisco in China push
Haisco Pharmaceutical has formed a new alliance with ARCH Venture Partners and Population Health, adding to its series of summer partnerships. The collaboration is part of a broader trend of Western biotech investors engaging with Chinese drugmakers. Specific terms of the deal were not detailed.
Related stories
Khartis Therapeutics Secures $50M Series B for Thyroid Eye Disease Treatment · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “ARCH and Population Health join China blitz with Haisco deal.” Browse more stories.